Sara Lonardi

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Sara Lonardi

Sep 24, 2024, 12:30 | Societies

11 ESMO24 presentations published on NEJM

At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…

Sep 17, 2024, 14:30 | Blog

Cathy Eng's highlights from ESMO24

The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…

Sep 10, 2024, 04:33 | Blog

Elias Karam: ACCENT pooled analysis published in JCO

Elias Karam, Hematology and Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn…

Sep 3, 2024, 13:11 | Insight

Julein Taieb: Real world evidence showing 50 MSI-H BRAF V600E mutant treated with immunotherapy

Julein Taieb, Professor, Paris Descartes University, shared a post on LinkedIn: "BRAFmutant, MSI, colorectal cancer…

Aug 7, 2024, 00:27 | Blog

Paolo Tarantino reflects on the results from DESTINY-CRC02 published in the Lancet Oncology

Paolo Tarantino shared on X: “Results from DESTINY-CRC02 published in the Lancet Oncology. Among patients…

Aug 5, 2024, 01:55 | Societies

Scientific Committees at the ESMO Congress 2024

The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…

Jul 29, 2024, 05:37 | Insight

Highlights in colorectal cancer at ASCO and ESMO GI 2024 by Video Journal of Oncology

David Tougeron, Professor at University of Poitiers Hospital, shared a post by Video Journal of…

Jul 2, 2024, 04:25 | OncoDaily Pulse

OncoDaily Party and Yvonne Award 2024 Photos - Part 2

On May 31st, 2024, during the ASCO Annual Meeting in Chicago, OncoDaily hosted the inaugural…

Jun 21, 2024, 02:08 | Insight

New Paper Alert! AtezoTRIBE Study

AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…

All: 9 Posts: 1 - 100